Why Multi-morbidity Requires Two Health Systems, not One

By JEREMY SHANE What’s behind the coming health care reckoning? Most industry leaders have their preferred list of culprits: not us! Left-leaning critics blame large insurers, drug companies, and private equity firms. Take the profit and self-dealing out of health care. Those on the right blame excessive regulation, poorly-designed insurance markets, or limits on individuals’…

Read More

Sobi Grows Its Gout Drug Prospects With $950M Acquisition of Startup Arthrosi Therapeutics

Arthrosi Therapeutics’ pozdeutinurad is in Phase 3 testing as a treatment for uncontrolled gout. Sobi says this once-daily capsule complements its own asset, an infused biologic medicine currently under FDA review as a third-line gout treatment. The post Sobi Grows Its Gout Drug Prospects With $950M Acquisition of Startup Arthrosi Therapeutics appeared first on MedCity…

Read More

New KFF-Washington Post Survey Explores Parents’ Trust In, and Confusion About, Childhood Vaccines as the Trump Administration Revamps Federal Policies

A new KFF-Washington Post partnership survey of parents explores their experiences with and views about vaccines for their children, including a look into how they make decisions related to vaccines and where they are uncertain or confused about their safety. The poll comes as the Trump administration’s Health and Human Services Secretary Robert F.

Read More

Phil Fasano, Recuro Health

Phil Fasano is CEO of Recuro Health. Phil was CIO at Kaiser Permanente in the glory years when it rolled out Epic/Health Connect, which was at the time the biggest roll out of an EMR and was instrumental in creating Kaiser’s system of virtual care. A decade+ later the concept of telehealth and virtual care…

Read More